Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway

Bibliographic Details
Main Authors:	Antonella Padella, Maria Chiara Fontana, Giovanni Marconi, Eugenio Fonzi, Elisabetta Petracci, Anna Ferrari, Carmen Baldazzi, Cristina Papayannidis, Andrea Ghelli Luserna Di Rorá, Nicoletta Testoni, Gastone Castellani, Torsten Haferlach, Giovanni Martinelli, Giorgia Simonetti
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-01-01
Series:	Blood Cancer Journal
Online Access:	https://doi.org/10.1038/s41408-020-00396-x

Similar Items

The balance between mitotic death and mitotic slippage in acute leukemia: a new therapeutic window?
by: Andrea Ghelli Luserna di Rorà, et al.
Published: (2019-11-01)

A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
by: Andrea Ghelli Luserna di Rorà, et al.
Published: (2020-09-01)

Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
by: Maria Chiara Fontana, et al.
Published: (2021-04-01)

The Inhibition of Chk1/Chk2 and Wee-1 Kinases as a Promising Therapy for the Treatment of Adult Acute Lymphoblastic Leukemia
by: Ghelli Luserna di Rorà, Andrea <1987>
Published: (2016)

The cell cycle checkpoint inhibitors in the treatment of leukemias
by: A. Ghelli Luserna di Rora’, et al.
Published: (2017-03-01)

Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
by: Michele Gottardi, et al.
Published: (2021-09-01)

Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation
by: Valentina Giudice, et al.
Published: (2020-12-01)

Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia
by: Samantha Bruno, et al.
Published: (2019-01-01)

Network integration of multi-tumour omics data suggests novel targeting strategies
by: Ítalo Faria do Valle, et al.
Published: (2018-10-01)

Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents
by: Giorgia Simonetti, et al.
Published: (2021-01-01)

Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2019-10-01)

Germline PALB2 Mutations in Cancers and Its Distinction From Somatic PALB2 Mutations in Breast Cancers
by: Zhe-Yu Hu, et al.
Published: (2020-08-01)

Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
by: Andrea Ghelli Luserna Di Rorà, et al.
Published: (2018-08-01)

PALB2 and breast cancer: ready for clinical translation!
by: Southey MC, et al.
Published: (2013-07-01)

Assessment of PALB2 as a candidate melanoma susceptibility gene.
by: Lauren G Aoude, et al.
Published: (2014-01-01)

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
by: Thales C. Nepomuceno, et al.
Published: (2017-08-01)

Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia
by: Giorgia Simonetti, et al.
Published: (2021-06-01)

Report of a germline double heterozygote in MSH2 and PALB2
by: Konstantinos Agiannitopoulos, et al.
Published: (2020-10-01)

Interaction with PALB2 Is Essential for Maintenance of Genomic Integrity by BRCA2.
by: Suzanne A Hartford, et al.
Published: (2016-08-01)

A novel t(2;10)(q31;p12) balanced translocation in acute myeloid leukemia
by: Luciana Impera, et al.
Published: (2012-12-01)

Bromodomain and extra-terminal motif proteins regulate linear and circular pvt1 in acute myeloid leukemia cells under normoxi and hypoxia
by: M. Ghetti, et al.
Published: (2020-09-01)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2021-01-01)

PALB2 genetik varyasyonlarının meme kanseri yatkınlığı üzerindeki etkilerinin araştırılması
by: Müge YÜKSEL BİLEN, et al.
Published: (2020-03-01)

Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
by: Gabriel S. Macedo, et al.
Published: (2019-04-01)

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
by: Shijie Wu, et al.
Published: (2020-02-01)

Characterisation of PALB2 tumours through whole-exome and whole-transcriptomic analyses
by: Pei Sze Ng, et al.
Published: (2021-04-01)

Recurrent gastrointestinal hemorrhage in treatment with dasatinib in a patient showing SMAD4 mutation with acute lymphoblastic leukemia Philadelphia positive and juvenile polyposis hereditary hemorrhagic telangiectasia syndrome
by: Chiara Sartor, et al.
Published: (2013-07-01)

Molecular and functional characterization of ABRAXAS and PALB2 genes in hereditary breast cancer predisposition
by: Bose, M. (Muthiah)
Published: (2019)

Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
by: Kodai Abe, et al.
Published: (2021-01-01)

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population
by: Philip Hilz, et al.
Published: (2019-07-01)

A novel germline <it>PALB2 </it>deletion in Polish breast and ovarian cancer patients
by: Cendrowski Krzysztof, et al.
Published: (2010-02-01)

Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma
by: Andrew Elliott, et al.
Published: (2020-12-01)

The role of PALB2 in BRCA1/2-mediated DNA repair and tumor suppression
by: Park, Dongju
Published: (2017)

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival
by: Giulia Corradi, et al.
Published: (2018-10-01)

Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
by: Torsten Haferlach
Published: (2020-09-01)

Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
by: Rick A. C. M. Boonen, et al.
Published: (2019-11-01)

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
by: Ryan Kahn, et al.
Published: (2016-08-01)

Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial
by: Claudio Cerchione, et al.
Published: (2020-02-01)

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma
by: Massimo Martino, et al.
Published: (2021-05-01)

Comparing Family Sharing Behaviors in <em>BRCA</em> Carriers with <em>PALB2</em> Carriers
by: Kechik, Joy E.
Published: (2019)